ENOV vs VTR · rev $1.17B vs P/E 149, rev $1.73B
Enovis Corp (ENOV) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Enovis Corp (ENOV) is a medical devices company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported ENOV revenue for 2026-07-03 was $1.17B. Net income was -$10.0M. Revenue was up 98.9% from 2026-04-03 to 2026-07-03. ENOV currently screens at market cap $1.37B.
Latest reported VTR revenue for 2026-06-30 was $1.73B. Net income was $72.2M. Revenue was up 4.4% from 2026-03-31 to 2026-06-30. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
ENOV currently screens at market cap $1.37B. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the ENOV and VTR stock pages for the full models.
Not investment advice.